IntegenX, Inc. (IXI) announced that it has been awarded a new contract by the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DoD) to develop an Integrated Sample-to-Sequence (ISS) system for rapid detection and identification of genetically engineered bacteria and viruses, medically relevant bacteria and viruses, and emerging pathogens…
Democrats are likely to again push to give billions in health coverage assistance to Ground Zero workers when they return from their recess, Roll Call reports. “A Democratic leadership aide said Tuesday that the bill likely would get the green light for floor action shortly after the House returns Sept. 14 in conjunction with events planned to commemorate the ninth anniversary of the Sept…
Researchers at Rice University have won federal support to develop a genomic test that can quickly determine whether a disease outbreak is caused by a natural pathogen or one that was grown in a lab by terrorists…
Imagine technology that allows you to get inside the mind of a terrorist to know how, when and where the next attack will occur. That’s not nearly as far-fetched as it seems, according to a new Northwestern University study…
Veritide Ltd., a developer of innovative biological identification and detection solutions, today reported that new independent data to be presented at the Biodetection Technologies 2009 conference confirm the exceptional accuracy of its Ceeker™ (pronounced “seeker”) portable bacterial detection device in discriminating between anthrax spores and similar-looking hoax substances.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded 25 new grants to develop new and better diagnostics and treatments for radiation exposure after a nuclear attack.
Scientists are finding that particles that are barely there - tiny objects known as nanoparticles that have found a home in electronics, food containers, sunscreens, and a variety of applications - can breech our most personal protective barrier: The skin. The particles under scrutiny by Lisa DeLouise, Ph.D., are almost unfathomably tiny. The particles are less than one five-thousandth the width of a human hair.
Fairway Medical Technologies, Inc. has received a $900,000, 3-year contract from the Department of the Navy to apply its optoacoustic technology to the real-time detection of blood borne pathogens and biological warfare agents under battlefield conditions. This grant is part of a larger, $3 million project led by Prof. Randolph Glickman, Principal Investigator from the University of Texas Health Science Center (UTHSC) at San Antonio.